Navigation Links
Elsevier's WiserWiki allows physicians to update evidence-based medical information
Date:1/29/2008

New York, January 29, 2008 Elsevier, the worlds leading publisher of science and health information, announced today the beta launch of WiserWiki (http://www.WiserWiki.com), a wiki that allows board-certified physicians to collaboratively contribute and update medical information online. The site, which is open to and viewable by the public, is seeded with content from The Textbook of Primary Care Medicine (3rd Edition, 2001) by John Noble, M.D. The textbook was published by Mosby, an Elsevier imprint, and was one of Elseviers best-selling medical textbooks.

WiserWiki is another example of Elseviers commitment to develop innovative tools for medical professionals, said Scott Virkler, Vice President, Business Development at Elsevier. With WiserWiki were providing a trusted forum for physicians to collaborate and contribute professional-level medical content thats viewable by members of the public.

No longer in print, the textbook seeding WiserWiki contains in-depth information on a full-range of medical problems, conditions and diseases encountered in the practices of family physicians, general internists, medical and surgical subspecialists, nurse practitioners, and physician assistants.

WiserWiki hopes to maintain a high level of relevancy and trustworthiness by ensuring that editorial privileges remain restricted to medical professionals.

As the use of online communities and the Internet has increased the possibilities for and benefits of sharing medical information and best practices with other patients and physicians have grown enormously, noted Dr. Noble. WiserWiki provides exposure for physicians who wish to publish relevant, up-to-date and insightful medical content based on personal experience and expertise.

Using WiserWiki

WiserWiki is free to users, and contributors retain the copyright to information they contribute to the site, subject to usa
'/>"/>

Contact: Tom Reller
t.reller@elsevier.com
212-462-1912
Elsevier
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Elseviers "WiserWiki" Allows Physicians to Update Evidence-Based Medical Information With Experience-Based Practice Insights
2. Donation of $15,000 and Hard Work Allows a Family in Need to Move into New Home
3. Microgrid allows simultaneous study of multiple variables
4. Computer simulator allows visually-impaired to drive
5. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
6. Anesthesia Pouch Allows Children to Go Home Sooner After Surgery
7. A new method allows for the early diagnosis of pulmonary hypertension
8. Mapping tool allows emergency management personnel to visually track resources
9. Broad-based group of physicians calls for improvement in stroke treatment
10. Latest DES Analysis Stresses Importance of Physicians Well-Trained in Implantation Technique and Patient Follow-Up
11. Psychiatrists are the least religious of all physicians

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ociation of Urology (EAU) and Europa Uomo, the Eur...state cancer, have entered into an,affiliated par...increase and improve,patient awareness in Europe ...Per-Anders Abrahamsson, Secretary-General of the E...ship, Europa Uomo will gain access to the latest i...
(Date:11/30/2009)...gs of gravy and dessert at the holiday table are e...ly thought. According to a new research report rec...tp://www.fasebj.org ), a diet that is high in fat ...ately cause our bodies to store too much fat. This... the already difficult task of converting high-fat...
(Date:11/30/2009)...SHENZHEN, China, Nov. 30 /PRNewswire-FirstCall/ - ...ical.com/ ) operating subsidiary Mellow Hope final...facturer of intravenous medication in India. This ...for Hard to Treat Diseases in the following quarte... company secures the supply of raw pharmaceutical ...
(Date:11/30/2009)...OLIS, Nov. 30 A new study has foun...Medicare insurance customers have a current intent... coverage. The figure is up from 20% in 2008. Ov...measure has been a leading indicator of actual swi...tention to switch actually will leave their curren...
(Date:11/30/2009)... and Senate bills stack up , , MONDAY, N...ills moving through the U.S. Congress differ in a ...ic reduction in the number of uninsured Americans....ntatives earlier this month would expand coverage ...g to debate a proposal to expand coverage to 94 pe...
Breaking Medicine News(10 mins):Health News:Western diets turn on fat genes 2Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 2Health News:Hard to Treat Diseases (HTDS) Closes 1 Million Dollar Contract Indian Pharmaceutical 3Health News:More Seniors Considering Health Insurance Switch 2Health News:Health Reform: What's in It for You? 2Health News:Health Reform: What's in It for You? 3
...ent of coronary artery diseases, in which a thin p...ains the medicine// which can prevent scar formati...the stent without surgery introduces drug. Sir...g blood clots in the arteries without surgical met...
...e grapefruit is a thing to cheer for people suffer...t people with gum disease who ate two grapefruits ...eeding from the gums. The study was performed ...an increase in blood levels of vitamin C, known to...
...d that cold and flu drugs containing pseudoephedri... in an effort to limit illegal manufacturing of su...effect from January 1 in Queensland. Pharmacists h...often used as a raw material to manufacture speed ...
...ts from tissue that may have been illegally harves... positive for hepatitis // and syphilis, their la...re Memorial Hospital in Somers Point, N.J., and cl...ases within the last two weeks. The lawyer, And...
...tsunami waves had left over 25,000 people dead and...Indian Ocean countries. // One in five Thai tsun...year's disaster that forever changed the physical,...nami survivors are still suffering the post trauma...
...hat can detect the Hepatitis C virus using saliva ...i of Soroka University Medical Centre // in Israe... people without kidney functions whose blood must ... The researchers reported 100 percent success...
Other Medicine News:
(Date:11/30/2009)..., WALTHAM, Mass., Nov. 30 Decis... and advisory firms focusing on pharmaceutical and... virus drug market in Russia will grow nine percen...hing $327 million by 2013. This growth will be dri...lthcare and increased use of more-expensive therap...
(Date:11/30/2009)... , INDIANAPOLIS, Nov. 30 /PRNewswire-FirstCall...as approved Cymbalta® (duloxetine HCl) for th...order (GAD) in adults, Eli Lilly and Company (NYSE...d anxiety disorder can be a chronic illness, it is...treatment option that is effective in both the acu...
(Date:11/30/2009)..., BRIDGEWATER, N.J., Nov. 30 /PRNewswire-FirstCall...ng of an exclusive licensing agreement with Intell...for the emergency treatment of allergic reactions ... ,, "We are pleased to have this opportunity to...lions of people who are at risk of this life-threa...
Breaking Medicine Technology:Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 2Russia's Hepatitis C Virus Drug Market Will Grow Nine Percent Annually, Reaching $327 Million by 2013 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 2FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 3FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 4FDA Approves Cymbalta(R) for Maintenance Treatment of Generalized Anxiety Disorder 5Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America 2Sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America 3China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 55810 1China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 55810 2China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 55810 3China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 55810 4China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 55810 5China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 55810 6China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 55810 7China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 55810 8China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 55810 9China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 55810 10China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 55810 11China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 55810 12China Medical Technologies Reports FY2009 First Fiscal Quarter Unaudited Financial Results 55810 13Head of Process Sciences at aTyr Pharma to Speak at Bio Korea 2009 4928 1Head of Process Sciences at aTyr Pharma to Speak at Bio Korea 2009 4928 2MarketsandMarkets 3A Global Autoimmune Treatment Market Worth US 2468 81 Billion by 2014 13750 1MarketsandMarkets 3A Global Autoimmune Treatment Market Worth US 2468 81 Billion by 2014 13750 2MarketsandMarkets 3A Global Autoimmune Treatment Market Worth US 2468 81 Billion by 2014 13750 3MarketsandMarkets 3A Global Autoimmune Treatment Market Worth US 2468 81 Billion by 2014 13750 4
... American Association for Cancer Research,annual m...ire-FirstCall/ --,Medarex, Inc. today presented pr...tivity from two separate studies exploring the,eff... anti-CD70,antibody-drug conjugates. CD19 and CD70...conjugate approach to cancer therapy. They are,exp...
...the American Association for Cancer Research,(AACR...- Lorus,Therapeutics Inc. ("Lorus") today announce... and siRNA compounds at the 98th,Annual Meeting of... The first presentation titled, "Determination of ...docetaxel combination,treatment for NSCLC cells in...
Other Medicine Technology:Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 2Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 3Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor,Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in,Cancer Animal Models 4Lorus Therapeutics Announces Scientific Presentations for Lead,Antisense and siRNA Drug Candidates at International Cancer,Conference 2Lorus Therapeutics Announces Scientific Presentations for Lead,Antisense and siRNA Drug Candidates at International Cancer,Conference 3Lorus Therapeutics Announces Scientific Presentations for Lead,Antisense and siRNA Drug Candidates at International Cancer,Conference 4Lorus Therapeutics Announces Scientific Presentations for Lead,Antisense and siRNA Drug Candidates at International Cancer,Conference 5
New Image Cut-to-Fit Convex Flextend Skin Barrier
CenterPointLock Urostomy Pouch
CenterPointLock Stoma Cap
CenterPointLock Sterile Drainable Kits
Medicine Products: